News for MiMedx Group, Inc. (MDXG)

Stanley Micek appointed as permanent Chief Operating Officer of Spectral AI (MDAI). Micek has over 25 years of experience in healthcare leadership. K

Craig-Hallum is set to host meetings featuring MDXG, scheduled for June 4 in Philadelphia and June 5 in Baltimore. These gatherings aim to provide investors wit

MARIETTA, Ga., May 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. ( MDXG) (”œMIMEDX” or the ”œCompany”) today announced that members of its senior mana

**media[637951]**

MARIETTA, Ga., May 06, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. ( MDXG) (”œMIMEDX” or the ”œCompany”) today announced that members of its senior mana

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

You may be concerned about the recent declines in AI stocks such as NVDA.

\nPropensity Score-Matched, Comparative Cost-Effectiveness Analysis of the Company's EPIFIX® Placental Allograft Product\n\nMARIETTA, Ga., May 05, 2025 (GLOBE N

On Thursday afternoon, MiMedx (MDXG) saw a 7% drop in its stock price, falling to $6.39, following the company's latest earnings report and a discussion about d

Mizuho has adjusted its price target for MiMedx (MDXG), reducing it from $15 to $12, while maintaining an Outperform rating on the stock. This change follows th

Craig-Hallum has adjusted its price target for MiMedx (MDXG), reducing it from $14 to $13, while maintaining a Buy rating on the stock. This decision follows th

Robust growth in Surgical product sales, showcasing a 16.2% increase compared to the previous year.Net sales increase of 4.1%, reaching $88.2 million for the f

Net Sales: $88 million, representing 4% growth year-over-year.Adjusted Gross Profit Margin: 84% for the quarter.Adjusted EBITDA: $17 million, or 20% of net sal

Apr 30, 2025 / 08:30PM GMTOperator Good afternoon and thank you for standing by. Welcome to the MIMEDX first quarter 2025 operating and financial results confer

MARIETTA, Ga., April 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. ( MDXG) (â\u0080\u009cMIMEDXâ\u0080\u009d or the â\u0080\u009cCompanyâ\u0080\u009d) today announced that it will report its opera

Mizuho has adjusted its price target for MiMedx Group (MDXG), reducing it from $16 to $15 while maintaining an Outperform rating on the stock. This adjustment c

The Centers for Medicare & Medicaid Services (CMS) has postponed the implementation of new coverage rules for certain skin substitute grafts until January 1, 20

Summary MiMedx Group Inc (MDXG), a leader in advanced wound care and surgical solutions, announced on April 10, 2025, its participation in several high-profile

**media[592023]**